Literature DB >> 7104800

Anaesthesia for cerebral arteriovenous malformations in children.

M E McLeod, R E Creighton, R P Humphreys.   

Abstract

Between 1966 and 1982, 46 patients underwent a total of 50 craniotomies for exploration and excision of cerebral arteriovenous malformations (AVMs) at The Hospital for Sick Children, Toronto. Thirty-three of these patients presented with intracranial haemorrhage, 13 of whom required emergency operations. Thirteen patients underwent elective surgery after investigation of a variety of medical complaints. In most cases, anesthesia was induced with thiopentone followed by a muscle relaxant to facilitate intubation. Anaesthesia was maintained with nitrous oxide and oxygen, a muscle relaxant, halothane and/or an intravenous narcotic, and positive pressure ventilation. In 60 percent of patients, blood loss was less than 20 per cent of estimated blood volume (EBV) although four children lost more than 50 per cent of their EBV. There were no deaths during operation. Controlled hypotension was employed in 30 operations to improve operating conditions during excision of deep-seated AVMs. Blood loss was similar in the non-hypotensive group, but these procedures tended to be of shorter duration. The advantages of various hypotensive techniques in children undergoing operations for cerebral AVMs are discussed and current anaesthetic management at The Hospital for Sick Children is described.

Entities:  

Mesh:

Year:  1982        PMID: 7104800     DOI: 10.1007/BF03007516

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  12 in total

1.  Hypothermia, and interruption of carotid, or carotid and vertebral circulation, in the surgical management of intracranial aneurysms.

Authors:  E H BOTTERELL; W M LOUGHEED; J W SCOTT; S L VANDEWATER
Journal:  J Neurosurg       Date:  1956-01       Impact factor: 5.115

2.  Reflex circulatory responses to direct laryngoscopy and tracheal intubation performed during general anesthesia.

Authors:  B D KING; L C HARRIS; F E GREIFENSTEIN; J D ELDER; R D DRIPPS
Journal:  Anesthesiology       Date:  1951-09       Impact factor: 7.892

3.  Circulatory changes during direct laryngoscopy and tracheal intubation: influence of duration of laryngoscopy with or without prior lidocaine.

Authors:  R K Stoelting
Journal:  Anesthesiology       Date:  1977-10       Impact factor: 7.892

4.  Cyanide toxicity and thiosulfate protection during chronic administration of sodium nitroprusside in the dog: correlation with a human case.

Authors:  J D Michenfelder; J H Tinker
Journal:  Anesthesiology       Date:  1977-11       Impact factor: 7.892

5.  Clinical analysis of arteriovenous malformations in children.

Authors:  K Mori; T Murata; N Hashimoto; H Handa
Journal:  Childs Brain       Date:  1980

6.  The effect of general anaesthesia on the tolerance of cerebral ischaemia in rabbits.

Authors:  J A Bain; D V Catton; J M Cox; W E Spoerel
Journal:  Can Anaesth Soc J       Date:  1967-03

7.  Report on the cooperative study of intracranial aneurysms and subarachnoid hemorrhage. Section VI. Arteriovenous malformations. An analysis of 545 cases of cranio-cerebral arteriovenous malformations and fistulae reported to the cooperative study.

Authors:  G Perret; H Nishioka
Journal:  J Neurosurg       Date:  1966-10       Impact factor: 5.115

8.  Cerebral arteriovenous malformations in children.

Authors:  S C So
Journal:  Childs Brain       Date:  1978

9.  Canine systemic and cerebral effects of hypotension induced by hemorrhage, trimethaphan, halothane, or nitroprusside.

Authors:  J D Michenfelder; R A Theye
Journal:  Anesthesiology       Date:  1977-03       Impact factor: 7.892

10.  Lidocaine or thiopental for rapid control of intracranial hypertension?

Authors:  R F Bedford; J A Persing; L Pobereskin; A Butler
Journal:  Anesth Analg       Date:  1980-06       Impact factor: 5.108

View more
  1 in total

Review 1.  Cerebral arteriovenous malformations in children.

Authors:  C Millar; B Bissonnette; R P Humphreys
Journal:  Can J Anaesth       Date:  1994-04       Impact factor: 5.063

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.